Diuretic combinations in critically ill patients with respiratory failure: A systematic review and meta-analysis.

Jean Maxime Côté, Nadir Goulamhoussen, Blaithin A McMahon, Patrick T Murray
{"title":"Diuretic combinations in critically ill patients with respiratory failure: A systematic review and meta-analysis.","authors":"Jean Maxime Côté,&nbsp;Nadir Goulamhoussen,&nbsp;Blaithin A McMahon,&nbsp;Patrick T Murray","doi":"10.5492/wjccm.v11.i3.178","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In patients with respiratory failure, loop diuretics remain the cornerstone of the treatment to maintain fluid balance, but resistance is common.</p><p><strong>Aim: </strong>To determine the efficacy and safety of common diuretic combinations in critically ill patients with respiratory failure.</p><p><strong>Methods: </strong>We searched MEDLINE, Embase, Cochrane Library and PROSPERO for studies reporting the effects of a combination of a loop diuretic with another class of diuretic. A meta-analysis using mean differences (MD) with 95% confidence interval (CI) was performed for the 24-h fluid balance (primary outcome) and the 24-h urine output, while descriptive statistics were used for safety events.</p><p><strong>Results: </strong>Nine studies totalling 440 patients from a total of 6510 citations were included. When compared to loop diuretics alone, the addition of a second diuretic is associated with an improved negative fluid balance at 24 h [MD: -1.06 L (95%CI: -1.46; -0.65)], driven by the combination of a thiazide plus furosemide [MD: -1.25 L (95%CI: -1.68; -0.82)], while no difference was observed with the combination of a loop-diuretic plus acetazolamide [MD: -0.40 L (95%CI: -0.96; 0.16)] or spironolactone [MD: -0.65 L (95%CI: -1.66; 0.36)]. Heterogeneity was high and the report of clinical and safety endpoints varied across studies.</p><p><strong>Conclusion: </strong>Based on limited evidence, the addition of a second diuretic to a loop diuretic may promote diuresis and negative fluid balance in patients with respiratory failure, but only when using a thiazide. Further larger trials to evaluate the safety and efficacy of such interventions in patients with respiratory failure are required.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/80/WJCCM-11-178.PMC9136719.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"世界危重病急救学杂志(英文版)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5492/wjccm.v11.i3.178","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: In patients with respiratory failure, loop diuretics remain the cornerstone of the treatment to maintain fluid balance, but resistance is common.

Aim: To determine the efficacy and safety of common diuretic combinations in critically ill patients with respiratory failure.

Methods: We searched MEDLINE, Embase, Cochrane Library and PROSPERO for studies reporting the effects of a combination of a loop diuretic with another class of diuretic. A meta-analysis using mean differences (MD) with 95% confidence interval (CI) was performed for the 24-h fluid balance (primary outcome) and the 24-h urine output, while descriptive statistics were used for safety events.

Results: Nine studies totalling 440 patients from a total of 6510 citations were included. When compared to loop diuretics alone, the addition of a second diuretic is associated with an improved negative fluid balance at 24 h [MD: -1.06 L (95%CI: -1.46; -0.65)], driven by the combination of a thiazide plus furosemide [MD: -1.25 L (95%CI: -1.68; -0.82)], while no difference was observed with the combination of a loop-diuretic plus acetazolamide [MD: -0.40 L (95%CI: -0.96; 0.16)] or spironolactone [MD: -0.65 L (95%CI: -1.66; 0.36)]. Heterogeneity was high and the report of clinical and safety endpoints varied across studies.

Conclusion: Based on limited evidence, the addition of a second diuretic to a loop diuretic may promote diuresis and negative fluid balance in patients with respiratory failure, but only when using a thiazide. Further larger trials to evaluate the safety and efficacy of such interventions in patients with respiratory failure are required.

利尿剂联合治疗危重患者呼吸衰竭:系统回顾和荟萃分析。
背景:在呼吸衰竭患者中,循环利尿剂仍然是维持体液平衡治疗的基础,但抵抗是常见的。目的:探讨常用利尿剂联合应用对危重呼吸衰竭患者的疗效和安全性。方法:我们检索了MEDLINE、Embase、Cochrane Library和PROSPERO,以报告一种环状利尿剂与另一种利尿剂联合使用的效果。采用95%可信区间(CI)的平均差异(MD)对24小时体液平衡(主要结局)和24小时尿量进行meta分析,同时对安全事件进行描述性统计。结果:纳入9项研究,共计440例患者,共6510次引用。与单独使用环状利尿剂相比,添加第二种利尿剂可改善24 h时的负体液平衡[MD: -1.06 L (95%CI: -1.46;-0.65)],由噻嗪类药物联合呋塞米驱动[MD: -1.25 L (95%CI: -1.68;-0.82)],而环利尿剂联合乙酰唑胺组无差异[MD: -0.40 L (95%CI: -0.96;0.16)]或螺内酯[MD: -0.65 L (95%CI: -1.66;0.36)]。异质性很高,临床和安全性终点的报告在不同的研究中有所不同。结论:基于有限的证据,在循环利尿剂的基础上添加第二种利尿剂可能促进呼吸衰竭患者的利尿和负体液平衡,但仅当使用噻嗪类药物时。需要进一步进行更大规模的试验来评估这些干预措施对呼吸衰竭患者的安全性和有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
216
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信